Imprint Wealth LLC Has $504,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Imprint Wealth LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 987 shares of the healthcare conglomerate’s stock after selling 30 shares during the period. Imprint Wealth LLC’s holdings in UnitedHealth Group were worth $504,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Robbins Farley acquired a new stake in UnitedHealth Group during the 3rd quarter worth approximately $25,000. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. CGC Financial Services LLC grew its stake in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. NewSquare Capital LLC grew its stake in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA grew its stake in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on UNH. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Morgan Stanley dropped their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Finally, Barclays began coverage on UnitedHealth Group in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price target for the company. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $573.80.

UnitedHealth Group Trading Up 6.2 %

UNH traded up $27.70 during trading on Tuesday, hitting $473.33. The company’s stock had a trading volume of 6,938,428 shares, compared to its average volume of 4,337,642. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. The stock’s fifty day moving average price is $491.15 and its 200-day moving average price is $515.88. The firm has a market capitalization of $436.38 billion, a P/E ratio of 19.62, a PEG ratio of 1.20 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.54 by $0.37. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the firm earned $6.26 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. Analysts anticipate that UnitedHealth Group Incorporated will post 27.7 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.59%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is 31.54%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.